Comparative Study of Amniotic Membrane Graft vs Mitomycin C with Conjunctival Autograft for Primary Pterygium Treatment
Not Applicable
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: H110- Pterygium of eye
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a. Patients diagnosed with primary pterygium.
b. Adults (18 years and older)
Exclusion Criteria
a. Patients with recurrent pterygium, severe ocular conditions, such as advanced glaucoma, corneal dystrophy, or significant ocular surface disease.
b. Combined surgical procedures at the time of surgery like trabeculectomy, cataract surgery.
c. Macular degeneration or any other retinal pathology were excluded.
d. With systemic connective tissue disorders.
e. Inability to give informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Recurrence rate in conjunctival autograft with 0.02% mitomycin c versus amniotic membrane graftTimepoint: Comparison of the effectiveness will be notice at 1 week and 1 month
- Secondary Outcome Measures
Name Time Method Recurrence rate in conjunctival autograft with 0.02% mitomycin c versus amniotic membrane graftTimepoint: Effectiveness of recurrence after 2 months